Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Mark J. Litton, PhD$77M
Market Cap • 24/04/20242011
(há 13 anos)
2020
(4 years ago)
NASDAQ
Listagem
Bothell
Sede • Washington64
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ATHASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.